Home › Funds › Atom Investors LP › ERAS
Atom Investors LP position in ERAS
ERASCA INC · Health Care
Atom Investors LP reported holding 549,915 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 0.55% of its reported portfolio and ranking #18 among its reported holdings. Atom Investors LP has disclosed ERAS holdings in 8 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Atom Investors LP's ERAS position evolved
Atom Investors LP first disclosed a stake in ERAS in Q1 2024 at 50,533 shares (US$104K). The position peaked in Q3 2026 at 549,915 shares, worth US$8.1M. Across 8 filings, Atom Investors LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 549,915 shares valued at US$8.1M — an increase of 390,104 shares quarter over quarter.. Notable position changes include a 57% increase in Q2 2024 (shares rose 16% over the following quarter), a 54% trim in Q2 2026 (shares fell 20% over the following quarter), a 244% increase in Q3 2026 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 50.53K | $104.10K | New |
| Q2 2024 | 79.53K | $187.69K | Add |
| Q4 2024 | 775.42K | $1.95M | New |
| Q1 2025 | 810.46K | $1.11M | Add |
| Q2 2025 | 549.96K | $698.45K | Reduce |
| Q1 2026 | 345.59K | $5.59M | New |
| Q2 2026 | 159.81K | $2.93M | Reduce |
| Q3 2026 | 549.91K | $8.06M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (ERASCA INC) is a Health Care company. 74 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$329.1M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- Frazier Life Sciences Management, L.P. 24.98M sh · $457.55M · Q2 2026
- RTW INVESTMENTS, LP 22.45M sh · $329.07M · Q3 2026
- Venrock Adviser, LLC 17.89M sh · $327.78M · Q2 2026
- Siren, L.L.C. 13.20M sh · $193.48M · Q3 2026
- ARCH Venture Management, LLC 7.09M sh · $129.92M · Q2 2026
- Paradigm Biocapital Advisors LP 8.00M sh · $117.25M · Q3 2026
- Cormorant Asset Management, LP 6.00M sh · $109.92M · Q2 2026
- Affinity Asset Advisors, LLC 5.59M sh · $81.96M · Q3 2026
- Vivo Capital, LLC 4.02M sh · $58.94M · Q3 2026
- a16z Capital Management, L.L.C. 2.86M sh · $52.44M · Q2 2026
- Soleus Capital Management, L.P. 2.70M sh · $49.46M · Q2 2026
- EcoR1 Capital, LLC 2.95M sh · $43.25M · Q3 2026
More on Atom Investors LP
FAQ
How long has Atom Investors LP held ERAS?
Atom Investors LP has disclosed ERAS holdings in 8 of the last 11 reported quarters, going back to Q1 2024.
What is Atom Investors LP's current position in ERAS?
As of Q3 2026, Atom Investors LP holds 549.91K shares of ERAS (ERASCA INC), valued at $8.06M, representing 0.55% of its reported portfolio and ranking #18.
Has Atom Investors LP been buying or selling ERAS?
In the latest 13F filing (Q3 2026), Atom Investors LP increased its position in ERAS. The position peaked in Q3 2026 at 549.91K shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.